Berikutnya

Putar otomatis

Kidney cancer: post-surgery sorafenib

0 Tampilan • 06/26/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Tim Eisen, MBBChir, PhD, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, describes the rationale and methodology behind the SORCE trial (NCT00492258) and what have we learned at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis